The special temporary authorization from the FCC means AST SpaceMobile can start beaming communications from its BlueBird ...

Johnson & Johnson , fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular , reported fourth-quarter ...

Maintaining optimal energy levels in today’s fast-paced world has become a challenge for many individuals. Whether due to a ...

StockNews.com upgraded shares of United States Cellular (NYSE:USM – Free Report) from a sell rating to a hold rating in a report published on Tuesday. A number of other equities research analysts have ...

The Lenovo ThinkPad X1 Carbon is synonymous with "portable," and Gen 13 is thinner and lighter than ever. It's almost unbelievable how easy this laptop is to move around, and it's built well enough ...

With its self-affirmed U.S. GRAS status, MitoEGT is now certified for a maximum addition level of 60 mg per serving in common food. It distinguishes itself as a prime option in its category, providing ...

Rick Wise, an analyst from Stifel Nicolaus, maintained the Hold rating on Johnson & Johnson (JNJ – Research Report). The associated price ...

Intra-Cellular Therapies makes Caplyta, a once-daily pill for adults with schizophrenia and bipolar-related depression ...

(Reuters) - Johnson & Johnson said on Monday it would buy neurological drug maker Intra-Cellular Therapies for ... after the company spun off its consumer health unit in 2023.

For beauty brands, 2025 calls for bold investments in transformative technologies and scientific advancements to secure the ...

Johnson & Johnson said on Monday it would buy neurological drug maker Intra-Cellular Therapies for $14.6 billion, its biggest ...

Whether you're shopping for a holistic health connoisseur or a fitness enthusiast or, our editors' favorite picks have you ...